Iovance Biotherapeutics Income Statement (2009-2025) | IOVA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2013 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.01M0.54M0.43M1.02M1.46M0.93M-1.40M-0.03M-12.78M-0.09M-16.73M-0.13M0.24M0.47M0.48M0.71M31.11M58.55M73.69M49.32M59.95M67.45M
Cost of Revenue 4.34M4.37M7.26M31.37M31.52M68.54M49.74M56.66M38.48M
Gross Profit -3.87M-3.88M-6.55M-0.26M27.04M5.16M-0.42M3.29M28.98M
Operating items
Amortization - Intangibles 2.60M0.50M
Research & Development 0.89M0.27M0.25M2.40M4.05M4.96M4.06M4.19M4.46M8.48M9.74M15.59M18.65M16.68M20.70M19.91M24.55M27.95M27.42M30.91M82.73M86.35M87.53M87.47M79.78M62.08M67.04M77.11M76.88M79.36M75.17M
Share-based Compensation (IS) 0.66M-20.02M
Selling, General & Administrative 0.00M0.00M0.03M0.14M0.23M0.17M2.90M2.38M2.68M4.42M2.82M7.26M10.50M6.18M5.29M4.93M5.66M5.38M6.96M6.83M7.11M7.53M9.08M28.12M21.93M26.96M29.90M31.39M39.57M39.34M43.07M43.92M37.70M34.55M
Restructuring Costs 5.14M
Other Operating Expenses -0.07M-0.14M0.50M0.66M10.56M5.81M4.18M2.25M1.38M1.38M2.05M4.34M4.37M7.26M31.37M41.25M40.09M49.74M56.66M47.48M
Operating Expenses 0.00M0.00M0.03M0.07M0.08M0.17M0.50M0.66M10.56M5.81M4.18M3.14M1.65M1.63M5.30M6.44M7.64M8.48M7.01M11.73M18.98M15.92M20.88M23.58M22.34M26.07M26.88M31.38M35.06M34.94M39.99M110.86M110.32M118.83M121.74M118.44M133.02M147.62M160.27M170.54M173.73M162.36M
Operating Income -0.07M-0.17M-0.50M-0.66M-10.56M-5.81M-4.18M-3.14M-1.65M-1.63M-5.30M-6.44M-7.64M-8.48M-7.01M-11.73M-18.98M-15.92M-20.88M-23.58M-22.34M-26.07M-26.88M-31.38M-35.06M-34.94M-39.99M-110.86M-110.09M-118.36M-121.26M-117.72M-101.91M-89.07M-86.58M-121.22M-113.77M-94.90M
EBIT -0.07M-0.17M-0.50M-0.66M-10.56M-5.81M-4.18M-3.14M-1.65M-1.63M-5.30M-6.44M-7.64M-8.48M-7.01M-11.73M-18.98M-15.92M-20.88M-23.58M-22.34M-26.07M-26.88M-31.38M-35.06M-34.94M-39.99M-110.86M-110.09M-118.36M-121.26M-117.72M-101.91M-89.07M-86.58M-121.22M-113.77M-94.90M
Non-operating items
Interest & Investment Income 0.13M0.16M0.22M0.23M0.20M0.20M0.19M0.22M0.36M0.72M1.23M2.37M3.04M3.49M3.08M3.36M3.12M3.34M3.35M4.00M9.57M3.22M4.10M1.24M
Other Non Operating Income -0.55M-0.25M0.09M-0.40M3.55M-7.72M-2.64M1.93M1.60M
Non Operating Income -0.55M-0.25M0.09M-0.00M-0.40M-2.64M1.32M0.95M
Net income details
EBT -0.07M-0.17M-0.50M-0.66M-10.56M-5.85M-4.18M-3.22M-1.76M-1.75M-5.30M-6.44M-7.64M-8.48M-6.88M-11.56M-18.76M-15.69M-20.68M-23.38M-22.15M-25.85M-26.52M-30.66M-33.83M-32.58M-36.95M-107.37M-107.00M-115.00M-118.14M-114.38M-98.56M-85.06M-77.00M-118.00M-109.67M-93.66M
Tax Provisions -0.50M-1.24M-1.78M-1.41M-1.50M-1.52M1.57M-1.84M2.00M-2.40M
Profit After Tax -0.00M-0.00M-0.00M-0.07M-0.08M-0.71M-0.74M-0.56M-10.96M-5.82M-8.35M-5.77M-0.33M-0.67M-4.65M-5.30M-6.37M-7.63M-8.36M-6.88M-11.56M-68.21M-15.69M-20.68M-23.38M-22.15M-25.85M-26.52M-30.66M-33.83M-32.58M-36.95M-107.37M-106.53M-113.76M-116.38M-112.98M-97.10M-83.54M-78.58M-116.20M-111.66M-91.25M
Income from Continuing Operations -0.07M-0.17M-0.50M-0.66M-10.56M-5.85M-4.18M-3.22M-1.76M-1.75M-5.30M-6.44M-7.64M-8.48M-6.88M-11.56M-18.76M-15.69M-20.68M-23.38M-22.15M-25.85M-26.52M-30.66M-33.83M-32.58M-36.95M-107.37M-106.50M-113.76M-116.36M-112.98M-97.06M-83.54M-78.57M-116.16M-111.67M-91.25M
Consolidated Net Income -0.07M-0.17M-0.50M-0.66M-10.56M-5.85M-4.18M-3.22M-1.76M-1.75M-5.30M-6.44M-7.64M-8.48M-6.88M-11.56M-18.76M-15.69M-20.68M-23.38M-22.15M-25.85M-26.52M-30.66M-33.83M-32.58M-36.95M-107.37M-106.50M-113.76M-116.36M-112.98M-97.06M-83.54M-78.57M-116.16M-111.67M-91.25M
Income towards Parent Company -0.07M-0.17M-0.50M-0.66M-10.56M-5.85M-4.18M-3.22M-1.76M-1.75M-5.30M-6.44M-7.64M-8.48M-6.88M-11.56M-18.76M-15.69M-20.68M-23.38M-22.15M-25.85M-26.52M-30.66M-33.83M-32.58M-36.95M-107.37M-106.50M-113.76M-116.36M-112.98M-97.06M-83.54M-78.57M-116.16M-111.67M-91.25M
Preferred Dividend Payments 49.45M
Net Income towards Common Stockholders -0.07M-0.17M-0.50M-0.66M-10.56M-5.85M-4.18M-3.22M-1.76M-1.75M-5.30M-6.44M-7.63M-8.36M-6.88M-11.56M-68.21M-15.69M-20.68M-23.38M-22.15M-25.85M-26.52M-30.66M-33.83M-32.58M-36.95M-107.37M-106.50M-113.76M-116.36M-112.98M-97.06M-83.54M-78.57M-116.16M-111.67M-91.25M
Additional items
EPS (Basic) -0.09-0.01-0.01-0.01-0.15-0.07-0.110.07-2.24-0.01-3.38-0.17-0.14-0.14-0.16-0.17-0.14-0.23-1.15-0.25-0.33-0.37-0.35-0.36-0.31-0.34-0.36-0.27-0.30-0.50-0.47-0.46-0.45-0.42-0.34-0.28-0.25-0.36-0.33-0.25
EPS (Weighted Average and Diluted) 0.000.00-0.01-0.01-0.14-0.50-0.47-0.46-0.45-0.42-0.34-0.28-0.25-0.36-0.33
Shares Outstanding (Weighted Average) 0.72M0.72M0.73M0.73M0.74M0.78M0.79M0.78M0.78M0.78M18.89M27.64M44.08M45.03M47.19M47.83M48.57M48.55M58.44M62.09M62.31M62.35M62.69M72.63M89.45M89.64M123.17M123.17M123.42M123.51M123.83M224.24M224.45M247.78M255.92M279.31M279.83M303.51M304.78M327.88M333.93M361.85M
Shares Outstanding (Diluted Average) 121.44M121.44M38.10M43.73M91.97M85.17M65.25M71.94M74.07M213.69M0.22M0.25M0.24M0.27M0.28M0.30M0.29M0.32M0.33M
EBITDA -0.07M-0.17M-0.50M-0.66M-10.56M-5.81M-4.18M-3.14M-1.65M-1.63M-5.30M-6.44M-7.64M-8.48M-7.01M-11.73M-18.98M-15.92M-20.88M-23.58M-22.34M-26.07M-26.88M-31.38M-35.06M-34.94M-39.99M-110.86M-110.09M-118.36M-121.26M-117.72M-101.91M-89.07M-86.58M-121.22M-113.77M-94.90M
Interest Expenses 0.03M0.09M0.11M0.13M55.80M
Tax Rate 0.47%1.08%1.51%1.23%1.52%1.79%1.56%2.57%